Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
10.3 INR | -2.46% |
|
+0.10% | +37.15% |
30/05 | Hemo Organic Appoints CFO | MT |
29/05 | Hemo Organic Limited Approves Appointment of Murlidhar Joshi as Chief Financial Officer | CI |
Sales 2022 | 68.3K 817.69 | Sales 2023 | 47.7K 571.06 | Capitalization | 24.61M 295K |
---|---|---|---|---|---|
Net income 2022 | - 0 | Net income 2023 | - 0 | EV / Sales 2022 | 2,607 x |
Net Debt 2022 | 258K 3.09K | Net cash position 2023 | 814K 9.75K | EV / Sales 2023 | 499 x |
P/E ratio 2022 |
-285
x | P/E ratio 2023 |
-45
x | Employees | 2 |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 0% |
1 day | -2.46% | ||
1 week | +0.10% | ||
Current month | -7.71% | ||
1 month | -2.55% | ||
3 months | +13.94% | ||
6 months | +39.00% | ||
Current year | +37.15% |
![Extreme 10.25](/images/extremecours_fleche.png)
![Extreme 10.1](/images/extremecours_fleche.png)
![Extreme 6.44](/images/extremecours_fleche.png)
![Extreme 5.57](/images/extremecours_fleche.png)
![Extreme 5.57](/images/extremecours_fleche.png)
![Extreme 5.57](/images/extremecours_fleche.png)
![Extreme 5.57](/images/extremecours_fleche.png)
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | - | 08/11 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 37 | - | |
Chief Executive Officer | - | 08/11 |
Date | Price | Change | Volume |
---|---|---|---|
14/24/14 | 10.3 | -2.46% | 2,353 |
13/24/13 | 10.56 | -3.83% | 13,106 |
12/24/12 | 10.98 | -1.17% | 6,816 |
11/24/11 | 11.11 | +2.87% | 14,359 |
10/24/10 | 10.8 | +4.96% | 6,371 |
Delayed Quote Bombay S.E., June 14, 2024 at 03:30 pm IST
More quotes- Stock Market
- Equities
- HEMORGANIC Stock